Polar Capital Holdings’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7M Buy
45,685
+2,814
+7% +$1.04M 0.04% 173
2026
Q1
$12.6M Sell
42,871
-2,197
-5% -$722K 0.04% 170
2025
Q4
$15.8M Sell
45,068
-354
-0.8% -$120K 0.06% 170
2025
Q3
$14.7M Sell
45,422
-11,352
-20% -$3.53M 0.07% 177
2025
Q2
$22.1M Buy
56,774
+762
+1% +$306K 0.12% 133
2025
Q1
$24.4M Buy
56,012
+12,000
+27% +$4.82M 0.15% 135
2024
Q4
$16.2M Hold
44,012
0.09% 161
2024
Q3
$22.9M Sell
44,012
-60,283
-58% -$32.2M 0.11% 133
2024
Q2
$56.5M Sell
104,295
-4,907
-4% -$2.59M 0.33% 75
2024
Q1
$56.6M Sell
109,202
-9,794
-8% -$4.87M 0.3% 81
2023
Q4
$56.1M Sell
118,996
-18,348
-13% -$8.48M 0.34% 83
2023
Q3
$59.8M Buy
137,344
+49,420
+56% +$22.4M 0.44% 65
2023
Q2
$39.1M Buy
87,924
+59,598
+210% +$27.5M 0.2% 99
2023
Q1
$13M Sell
28,326
-12,010
-30% -$5.72M 0.08% 171
2022
Q4
$20.7M Sell
40,336
-10,713
-21% -$5.44M 0.16% 143
2022
Q3
$23.2M Buy
51,049
+1,205
+2% +$577K 0.15% 129
2022
Q2
$24.1M Sell
49,844
-16,218
-25% -$8.02M 0.14% 126
2022
Q1
$32.5M Sell
66,062
-14,698
-18% -$6.72M 0.15% 123
2021
Q4
$37.4M Sell
80,760
-19,480
-19% -$8.2M 0.14% 119
2021
Q3
$37.4M Sell
100,240
-1,967
-2% -$748K 0.15% 119
2021
Q2
$39M Sell
102,207
-1,793
-2% -$685K 0.17% 116
2021
Q1
$37.3M Buy
104,000
+10,778
+12% +$3.47M 0.23% 110
2020
Q4
$29.9M Buy
+93,222
New +$28.6M 0.18% 122

Other funds holding ELV

Polar Capital Holdings's ELV Position: Q2 2026 in Review

Polar Capital Holdings increased its Elevance Health (ELV) stake by 6.6% in Q2 2026, buying an estimated $1.04M and bringing the position to 45,685 shares worth $17.7M. The position accounts for 0.04% of the portfolio, ranked #173.

Polar Capital Holdings first reported a position in ELV in Q4 2020 and has held it in 23 quarters since. The position peaked at $59.8M in Q3 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Polar Capital Holdings held 45,685 shares of Elevance Health worth $17.7M as of Q2 2026.
  • Polar Capital Holdings bought 2,814 Elevance Health shares in Q2 2026, an estimated $1.04M.
  • Elevance Health made up 0.04% of Polar Capital Holdings's portfolio in Q2 2026, its #173 holding.
  • Polar Capital Holdings first reported a position in Elevance Health in Q4 2020 and has held it in 23 quarters since.
  • Polar Capital Holdings's Elevance Health position peaked at $59.8M in Q3 2023.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Polar Capital Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.